The Role of Group B Strep Screening in Supporting Newborn Health
Group B Streptococcus (GBS) screening is a preventive health measure that involves testing pregnant women to identify the presence of GBS bacteria, helping healthcare teams prepare appropriate care strategies for labour and delivery.
Group B Streptococcus is a type of bacteria naturally found in the digestive and reproductive systems of many healthy adults. Approximately 20–25% of pregnant women carry GBS without experiencing any symptoms or health complications themselves. Understanding the role of GBS screening helps expectant parents make informed decisions about their pregnancy care whilst working alongside their healthcare professionals.
What Is Group B Streptococcus?
While GBS poses no significant health concerns for healthy adults, its presence during pregnancy requires careful monitoring due to potential transmission risks during delivery. The bacteria typically resides in:
- The intestinal tract
- The vaginal area
- The urinary system
Practical Insight: GBS colonisation can fluctuate throughout pregnancy, which is why timing of screening tests is carefully considered by healthcare professionals.
Understanding GBS Screening During Pregnancy
When Is GBS Screening Performed?
GBS screening typically occurs between 35–37 weeks of pregnancy, as this timing provides the most accurate indication of GBS status at the time of delivery. Testing earlier in pregnancy may not reflect the bacterial status during labour. The screening process involves:
- A simple swab test of the vaginal and rectal areas
- Laboratory analysis to detect GBS bacteria
- Results typically available within 2–3 days
Who Should Consider GBS Testing?
In the UK, universal GBS screening is not routinely offered through the NHS. However, healthcare providers may recommend testing based on individual circumstances, and private screening is available for those who wish to be tested. Certain situations may make testing particularly worth considering:
- Previous pregnancy affected by GBS
- Planned vaginal delivery
- First-time mothers seeking comprehensive pregnancy monitoring
- Women with risk factors such as prolonged labour or early membrane rupture
GBS Screening Methods and Accuracy
| Screening Method | Timing | Accuracy Rate | Collection Method |
|---|---|---|---|
| Culture Test | 35–37 weeks | High (varies by lab) | Vaginal/rectal swab |
| PCR Test | 35–37 weeks | High (varies by lab) | Vaginal/rectal swab |
| Urine Culture | If UTI suspected | Variable | Urine sample |
The culture method remains the gold standard for GBS screening, offering reliable results that help guide pregnancy care decisions. Expectant mothers seeking early infection testing for a healthy pregnancy can coordinate GBS screening alongside other third-trimester tests.
Note on test availability: The screening methods described above (vaginal/rectal swab culture and PCR) are specialist laboratory procedures. Our antenatal screening service provides comprehensive blood-based infection and immunity testing, including FBC, blood group and Rh type, syphilis, HIV, hepatitis B/C, rubella, varicella, and thyroid function. If you are specifically seeking GBS swab testing, please discuss this with your midwife, GP, or an obstetric specialist who can direct you to an appropriate laboratory service.
What GBS Screening Results Mean
Positive GBS Result
A positive result indicates the presence of GBS bacteria at the time of testing. This finding:
- Affects approximately 20–25% of pregnant women
- Does not indicate illness in the mother
- May influence labour and delivery planning
- Requires discussion with healthcare professionals about next steps
Negative GBS Result
A negative result suggests GBS bacteria were not detected during testing. However, GBS status can change between testing and delivery, so some risk factors may still warrant monitoring during labour.
Practical Insight: GBS screening results provide a snapshot of bacterial status at testing time, helping healthcare teams prepare appropriate care strategies for labour and delivery.
GBS Screening in the UK Healthcare System
NHS Guidelines and Recommendations
The UK approach to GBS screening differs from some international protocols:
- Universal screening is not routinely offered through the NHS
- A risk-based approach focuses on high-risk pregnancies
- Private screening options are available for comprehensive testing
- Individual healthcare providers may recommend testing based on specific circumstances
Private Screening Options in London
Many expectant parents in London choose private antenatal screening for comprehensive pregnancy monitoring, early identification of infection risks, and peace of mind during pregnancy. Our private antenatal service offers a detailed blood-based infection and immunity panel, covering blood group, haemoglobin, syphilis, HIV, hepatitis B/C, rubella, varicella, toxoplasma, and thyroid function — providing a thorough third-trimester health picture. This can be explored further through our guide on antibody screening in antenatal care in London. For a wider perspective on the value of proactive antenatal testing, see our guide on why private antenatal infection screening is vital. For GBS swab testing specifically, please consult your midwife or GP for a specialist referral.
Integrating GBS Screening with Comprehensive Pregnancy Care
Coordination with Other Tests
GBS screening often coordinates well with other pregnancy monitoring tests including infection screening panels, nutritional status evaluations, and comprehensive pregnancy health checks. For a broader view of infection-related pregnancy testing, see our guide on the scope of comprehensive antenatal immunity panels. Those in the pre-conception stage may also benefit from our clinical guide to hormone testing timing, as reproductive hormone assessments are often planned alongside antenatal screening.
Risk Factors and Prevention Approaches
Certain factors may increase the likelihood of GBS transmission:
- Prolonged membrane rupture (over 18 hours)
- Fever during labour
- Previous baby affected by GBS
- Delivery before 37 weeks
When GBS is detected, healthcare professionals may consider antibiotic administration during labour, enhanced monitoring during delivery, and newborn observation protocols.
Frequently Asked Questions
What is Group B strep screening and why is it important during pregnancy?
Group B strep screening is a simple test that detects GBS bacteria in pregnant women. While harmless to adults, GBS can occasionally affect newborns during delivery, making screening valuable for informed pregnancy planning.
When should GBS screening be performed during pregnancy?
GBS testing is typically performed between 35–37 weeks of pregnancy. This timing provides the most accurate indication of GBS status at the time of delivery.
Is GBS screening routinely available on the NHS?
The NHS uses a risk-based approach rather than universal screening. Private screening options are available for women seeking comprehensive GBS testing during pregnancy.
Can GBS status change between testing and delivery?
Yes, GBS colonisation can fluctuate throughout pregnancy. This is why testing is performed close to the expected delivery date for the most relevant results.
Should I have GBS screening if I had a positive result in a previous pregnancy?
Previous GBS-positive pregnancies may indicate higher likelihood of colonisation, making screening particularly valuable for informed planning. Each pregnancy should be assessed individually with appropriate healthcare professionals.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. All decisions regarding GBS testing and pregnancy care should be made in consultation with a qualified healthcare professional. If you have concerns about pregnancy health or GBS screening, please consult your midwife, GP, or appropriate healthcare services.
Written Date: 2nd June 2026 | Next Review Date: 2nd June 2027